Stocks and Investing
Stocks and Investing
Wed, May 29, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
George Sellers Reiterated (ANIK) at Hold and Held Target at $24 on, May 29th, 2024
George Sellers of Stephens & Co., Reiterated "Anika Therapeutics, Inc." (ANIK) at Hold and Held Target at $24 on, May 29th, 2024.
George has made no other calls on ANIK in the last 4 months.
There is 1 other peer that has a rating on ANIK. Out of the 1 peers that are also analyzing ANIK, 0 agree with George's Rating of Hold.
This is the rating of the analyst that currently disagrees with George
- Michael Petusky of "Barrington Research" Maintained at Buy and Held Target at $37 on, Thursday, May 9th, 2024
Contributing Sources